Association Study of CRP Gene and Ischemic Stroke in a Chinese Han Population

Journal of Molecular Neuroscience

Volumn 49, Issue 3, 2013, Pages 559-566

  Shen, Chong ^a   Sun, Xiaoyang ^a   Wang, Hairu ^a   Wang, Bing ^a   Xue, Yong ^b   Li, Yun ^c   Chen, Jinfeng ^a   Jiang, Yuzhang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Huai'an Third People's Hospital of Huai'an   (China)

^c HEBEI UNITED UNIVERSITY   (China)

Author keywords

C reactive protein (CRP) gene; High sensitivity C reactive protein; Ischemic stroke

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALLELE; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; CASE STUDY; CHINESE; CONTROL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHINA; COMORBIDITY; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PREVALENCE; RISK FACTOR;

AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMORBIDITY; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS;

MLCS; MLOWN;

EID: 84880646222     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9856-8     Document Type: Article

References (41)

1. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A et al (2003) C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34(10):2463-2468
2. Ben-Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Shopin L, Peretz H et al (2007) Triggered C-reactive protein (CRP) concentrations and the CRP gene -717A>G polymorphism in acute stroke or transient ischemic attack. Eur J Neurol 14(3):315-320
3. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C (2002) World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 106(13):1602-1605
4. Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P et al (2002) Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 155(1):38-47
5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14):1387-1397
6. den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ et al (2009) C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol 256(12):2003-2008
7. den Hertog HM, van den Herik EG, Dippel DW, Koudstaal PJ, de Maat MP (2010) Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke. Cerebrovasc Dis 29(4):372-375
8. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36(6):1316-1329
9. Dickinson CJ (2003) Strokes and their relationship to hypertension. Curr Opin Nephrol Hypertens 12(1):91-96
10. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391-397
11. Eastern Stroke and Coronary Heart Disease Collaborative Research Group (1998) Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 352(9143):1801-1807
12. Elkind MS, Luna JM, Coffey CS, McClure LA, Liu KM, Spitalnik S et al (2010) The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke. Int J Stroke 5(2):117-125
13. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF et al (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302(1):37-48
14. Fisher M (2004) The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis 17(Suppl 1):1-6
15. Genest J (2010) C-reactive protein: risk factor, biomarker and/or therapeutic target? Can J Cardiol 26(Suppl A):41A-44A
16. Hajat C, Heuschmann PU, Coshall C, Padayachee S, Chambers J, Rudd AG et al (2010) Incidence of aetiological subtypes of stroke in a multi-ethnic population based study: the South London Stroke Register. J Neurol Neurosurg Psychiatry 82(5):527-533
17. Khreiss T, Jozsef L, Potempa LA, Filep JG (2004) Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109(16):2016-2022
18. Lee CC, You NC, Song Y, Hsu YH, Manson J, Nathan L et al (2009) Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort. Clin Chem 55(2):351-360
19. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43(1):52-58
20. Masia M, Bernal E, Padilla S, Graells ML, Jarrin I, Almenar MV et al (2007) The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients. Atherosclerosis 195(1):167-171
21. McGeer PL, McGeer EG (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22(6):799-809
22. Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R et al (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69(Pt 6):623-638
23. Montaner J, Fernandez-Cadenas I, Molina CA, Ribo M, Huertas R, Rosell A et al (2006) Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke 37(5):1205-1210
24. Paffen E, DeMaat MP (2006) C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 71(1):30-39
25. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499-511
26. Purroy F, Montaner J, Molina CA, Delgado P, Arenillas JF, Chacon P et al (2007) C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 115(1):60-66
27. Ridker PM, Glynn RJ, Hennekens CH (1998) C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97(20):2007-2011
28. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12):836-843
29. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340(2):115-126
30. Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP (2002) C-reactive protein and myocardial infarction. J Clin Epidemiol 55(5):445-451
31. Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, Chung SW (2009) Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis 28(6):545-550
32. Stoll G, Bendszus M (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37(7):1923-1932
33. Suk HJ, Ridker PM, Cook NR, Zee RY (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178(1):139-145
34. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ et al (2005) C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112(6):900-905
35. Wang Q, Ding H, Tang JR, Zhang L, Xu YJ, Yan JT et al (2009a) C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacol Sin 30(3):291-298
36. Wang L, Lu X, Li Y, Li H, Chen S, Gu D (2009b) Functional analysis of the C-reactive protein (CRP) gene -717A>G polymorphism associated with coronary heart disease. BMC Med Genet 10:73
37. Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ (2009) Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 27(3):247-253
38. Wilson AM, Ryan MC, Boyle AJ (2006) The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 106(3):291-297
39. Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7(2):77-86
40. Wu S, Li Y, Jin C, Yang P, Li D, Li H et al (2011) Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. Int J Cardiol 157(1):75-79
41. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2009) C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease. Scand J Clin Lab Invest 69(4):442-446